0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rosuvastatin Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-0H9284
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Rosuvastatin Drugs Market Research Report 2022
BUY CHAPTERS

Global Rosuvastatin Drugs Market Research Report 2025

Code: QYRE-Auto-0H9284
Report
July 2025
Pages:65
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rosuvastatin Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rosuvastatin Drugs Market

Rosuvastatin Drugs Market

The global market for Rosuvastatin Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Drugs.
The Rosuvastatin Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rosuvastatin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rosuvastatin Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rosuvastatin Drugs Market Report

Report Metric Details
Report Name Rosuvastatin Drugs Market
CAGR 5%
Segment by Type
  • 5 mg Tablet
  • 10 mg Tablet
  • 20 mg Tablet
  • 40 mg Tablet
Segment by Application
  • Hyperlipidemia And Mixed Dyslipidemia
  • Familial Hypercholesterolemia
  • Hypertriglyceridemia
  • Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
  • Atherosclerosis
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Watson, ANGITA, Sun Pharmaceutical Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rosuvastatin Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rosuvastatin Drugs Market report?

Ans: The main players in the Rosuvastatin Drugs Market are AstraZeneca, Watson, ANGITA, Sun Pharmaceutical Industries

What are the Application segmentation covered in the Rosuvastatin Drugs Market report?

Ans: The Applications covered in the Rosuvastatin Drugs Market report are Hyperlipidemia And Mixed Dyslipidemia, Familial Hypercholesterolemia, Hypertriglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), Atherosclerosis, Others

What are the Type segmentation covered in the Rosuvastatin Drugs Market report?

Ans: The Types covered in the Rosuvastatin Drugs Market report are 5 mg Tablet, 10 mg Tablet, 20 mg Tablet, 40 mg Tablet

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rosuvastatin Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.2.4 20 mg Tablet
1.2.5 40 mg Tablet
1.3 Market by Application
1.3.1 Global Rosuvastatin Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hyperlipidemia And Mixed Dyslipidemia
1.3.3 Familial Hypercholesterolemia
1.3.4 Hypertriglyceridemia
1.3.5 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
1.3.6 Atherosclerosis
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rosuvastatin Drugs Market Perspective (2020-2031)
2.2 Global Rosuvastatin Drugs Growth Trends by Region
2.2.1 Global Rosuvastatin Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rosuvastatin Drugs Historic Market Size by Region (2020-2025)
2.2.3 Rosuvastatin Drugs Forecasted Market Size by Region (2026-2031)
2.3 Rosuvastatin Drugs Market Dynamics
2.3.1 Rosuvastatin Drugs Industry Trends
2.3.2 Rosuvastatin Drugs Market Drivers
2.3.3 Rosuvastatin Drugs Market Challenges
2.3.4 Rosuvastatin Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rosuvastatin Drugs Players by Revenue
3.1.1 Global Top Rosuvastatin Drugs Players by Revenue (2020-2025)
3.1.2 Global Rosuvastatin Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Rosuvastatin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rosuvastatin Drugs Revenue
3.4 Global Rosuvastatin Drugs Market Concentration Ratio
3.4.1 Global Rosuvastatin Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rosuvastatin Drugs Revenue in 2024
3.5 Global Key Players of Rosuvastatin Drugs Head office and Area Served
3.6 Global Key Players of Rosuvastatin Drugs, Product and Application
3.7 Global Key Players of Rosuvastatin Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rosuvastatin Drugs Breakdown Data by Type
4.1 Global Rosuvastatin Drugs Historic Market Size by Type (2020-2025)
4.2 Global Rosuvastatin Drugs Forecasted Market Size by Type (2026-2031)
5 Rosuvastatin Drugs Breakdown Data by Application
5.1 Global Rosuvastatin Drugs Historic Market Size by Application (2020-2025)
5.2 Global Rosuvastatin Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rosuvastatin Drugs Market Size (2020-2031)
6.2 North America Rosuvastatin Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rosuvastatin Drugs Market Size by Country (2020-2025)
6.4 North America Rosuvastatin Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rosuvastatin Drugs Market Size (2020-2031)
7.2 Europe Rosuvastatin Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rosuvastatin Drugs Market Size by Country (2020-2025)
7.4 Europe Rosuvastatin Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rosuvastatin Drugs Market Size (2020-2031)
8.2 Asia-Pacific Rosuvastatin Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rosuvastatin Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Rosuvastatin Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rosuvastatin Drugs Market Size (2020-2031)
9.2 Latin America Rosuvastatin Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rosuvastatin Drugs Market Size by Country (2020-2025)
9.4 Latin America Rosuvastatin Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rosuvastatin Drugs Market Size (2020-2031)
10.2 Middle East & Africa Rosuvastatin Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rosuvastatin Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Rosuvastatin Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Rosuvastatin Drugs Introduction
11.1.4 AstraZeneca Revenue in Rosuvastatin Drugs Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Watson
11.2.1 Watson Company Details
11.2.2 Watson Business Overview
11.2.3 Watson Rosuvastatin Drugs Introduction
11.2.4 Watson Revenue in Rosuvastatin Drugs Business (2020-2025)
11.2.5 Watson Recent Development
11.3 ANGITA
11.3.1 ANGITA Company Details
11.3.2 ANGITA Business Overview
11.3.3 ANGITA Rosuvastatin Drugs Introduction
11.3.4 ANGITA Revenue in Rosuvastatin Drugs Business (2020-2025)
11.3.5 ANGITA Recent Development
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Details
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Rosuvastatin Drugs Business (2020-2025)
11.4.5 Sun Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Rosuvastatin Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 5 mg Tablet
 Table 3. Key Players of 10 mg Tablet
 Table 4. Key Players of 20 mg Tablet
 Table 5. Key Players of 40 mg Tablet
 Table 6. Global Rosuvastatin Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Rosuvastatin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Rosuvastatin Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Rosuvastatin Drugs Market Share by Region (2020-2025)
 Table 10. Global Rosuvastatin Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Rosuvastatin Drugs Market Share by Region (2026-2031)
 Table 12. Rosuvastatin Drugs Market Trends
 Table 13. Rosuvastatin Drugs Market Drivers
 Table 14. Rosuvastatin Drugs Market Challenges
 Table 15. Rosuvastatin Drugs Market Restraints
 Table 16. Global Rosuvastatin Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Rosuvastatin Drugs Market Share by Players (2020-2025)
 Table 18. Global Top Rosuvastatin Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin Drugs as of 2024)
 Table 19. Ranking of Global Top Rosuvastatin Drugs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Rosuvastatin Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Rosuvastatin Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Rosuvastatin Drugs, Product and Application
 Table 23. Global Key Players of Rosuvastatin Drugs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Rosuvastatin Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Rosuvastatin Drugs Revenue Market Share by Type (2020-2025)
 Table 27. Global Rosuvastatin Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Rosuvastatin Drugs Revenue Market Share by Type (2026-2031)
 Table 29. Global Rosuvastatin Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Rosuvastatin Drugs Revenue Market Share by Application (2020-2025)
 Table 31. Global Rosuvastatin Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Rosuvastatin Drugs Revenue Market Share by Application (2026-2031)
 Table 33. North America Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Rosuvastatin Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Rosuvastatin Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Rosuvastatin Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Rosuvastatin Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Rosuvastatin Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Rosuvastatin Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Rosuvastatin Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Rosuvastatin Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rosuvastatin Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Rosuvastatin Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Rosuvastatin Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. AstraZeneca Company Details
 Table 49. AstraZeneca Business Overview
 Table 50. AstraZeneca Rosuvastatin Drugs Product
 Table 51. AstraZeneca Revenue in Rosuvastatin Drugs Business (2020-2025) & (US$ Million)
 Table 52. AstraZeneca Recent Development
 Table 53. Watson Company Details
 Table 54. Watson Business Overview
 Table 55. Watson Rosuvastatin Drugs Product
 Table 56. Watson Revenue in Rosuvastatin Drugs Business (2020-2025) & (US$ Million)
 Table 57. Watson Recent Development
 Table 58. ANGITA Company Details
 Table 59. ANGITA Business Overview
 Table 60. ANGITA Rosuvastatin Drugs Product
 Table 61. ANGITA Revenue in Rosuvastatin Drugs Business (2020-2025) & (US$ Million)
 Table 62. ANGITA Recent Development
 Table 63. Sun Pharmaceutical Industries Company Details
 Table 64. Sun Pharmaceutical Industries Business Overview
 Table 65. Sun Pharmaceutical Industries Rosuvastatin Drugs Product
 Table 66. Sun Pharmaceutical Industries Revenue in Rosuvastatin Drugs Business (2020-2025) & (US$ Million)
 Table 67. Sun Pharmaceutical Industries Recent Development
 Table 68. Research Programs/Design for This Report
 Table 69. Key Data Information from Secondary Sources
 Table 70. Key Data Information from Primary Sources
 Table 71. Authors List of This Report


List of Figures
 Figure 1. Rosuvastatin Drugs Picture
 Figure 2. Global Rosuvastatin Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rosuvastatin Drugs Market Share by Type: 2024 VS 2031
 Figure 4. 5 mg Tablet Features
 Figure 5. 10 mg Tablet Features
 Figure 6. 20 mg Tablet Features
 Figure 7. 40 mg Tablet Features
 Figure 8. Global Rosuvastatin Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Rosuvastatin Drugs Market Share by Application: 2024 VS 2031
 Figure 10. Hyperlipidemia And Mixed Dyslipidemia Case Studies
 Figure 11. Familial Hypercholesterolemia Case Studies
 Figure 12. Hypertriglyceridemia Case Studies
 Figure 13. Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Case Studies
 Figure 14. Atherosclerosis Case Studies
 Figure 15. Others Case Studies
 Figure 16. Rosuvastatin Drugs Report Years Considered
 Figure 17. Global Rosuvastatin Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Rosuvastatin Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Rosuvastatin Drugs Market Share by Region: 2024 VS 2031
 Figure 20. Global Rosuvastatin Drugs Market Share by Players in 2024
 Figure 21. Global Top Rosuvastatin Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin Drugs as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Rosuvastatin Drugs Revenue in 2024
 Figure 23. North America Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Rosuvastatin Drugs Market Share by Country (2020-2031)
 Figure 25. United States Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Rosuvastatin Drugs Market Share by Country (2020-2031)
 Figure 29. Germany Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Rosuvastatin Drugs Market Share by Region (2020-2031)
 Figure 37. China Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Rosuvastatin Drugs Market Share by Country (2020-2031)
 Figure 45. Mexico Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Rosuvastatin Drugs Market Share by Country (2020-2031)
 Figure 49. Turkey Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Rosuvastatin Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. AstraZeneca Revenue Growth Rate in Rosuvastatin Drugs Business (2020-2025)
 Figure 53. Watson Revenue Growth Rate in Rosuvastatin Drugs Business (2020-2025)
 Figure 54. ANGITA Revenue Growth Rate in Rosuvastatin Drugs Business (2020-2025)
 Figure 55. Sun Pharmaceutical Industries Revenue Growth Rate in Rosuvastatin Drugs Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS